664.1000 -20.15 (-2.94%)
NSE Jun 02, 2025 15:31 PM
Volume: 639.9K
 

Prabhudas Lilladhar
YoY, adj for one offs; was in line with our estimates. Our FY26E/FY27E EBITDA broadly remain unchanged. The company is on track to commercialize greenfield expansions across Thane and Bengaluru markets by H1FY26. New leadership team hiring across Karnataka and Kerala provides comfort for faster ramp-up in these clusters. Given its lean cost structure and partnership...
Prabhudas Lilladhar released a Buy report for Krishna Institute of Medical Sciences Ltd. with a price target of 725.0 on 14 May, 2025.
More from Krishna Institute of Medical Sciences Ltd.
Recommended